Suppr超能文献

第二阶段肿瘤启动子:C6细胞中生物活性和佛波酯受体亲和力的差异

Second stage tumor promoters: differences in biological potency and phorbol ester receptor affinity in C6 cells.

作者信息

Leach K L, Frost M M, Blumberg P M, Bressler J P

出版信息

Cancer Lett. 1987 Aug;36(2):139-47. doi: 10.1016/0304-3835(87)90085-1.

Abstract

We have shown that the second stage tumor promoters mezerein (MEZ) and phorbol 12-retinoate 13-acetate (PRA) inhibit the gluccocorticoid-induced increase in glycerol phosphate dehydrogenase (GPDH) activity in C6 rat glioma cells with ED 50-values of 3.9 and 2.9 nM, respectively. Phorbol 12-myristate 13-acetate (PMA) was 10-fold less potent. MEZ was likewise more potent than PMA for inhibition of cAMP formation in response to isoproterenol. Binding competition studies using [3H]phorbol 12,13-dibutyrate ([3H]PDBu) yielded apparent Ki-values for MEZ and PRA of 50-70 nM. The large difference between the biological potencies of MEZ and PRA and their affinity for the major phorbol ester receptor suggest they may be acting through a more complicated mechanism in these cells.

摘要

我们已经证明,第二阶段肿瘤启动子芫花酯甲(MEZ)和佛波醇12-视黄酸13-乙酸酯(PRA)可抑制糖皮质激素诱导的C6大鼠胶质瘤细胞中磷酸甘油脱氢酶(GPDH)活性的增加,其半数有效剂量(ED50)值分别为3.9和2.9 nM。佛波醇12-肉豆蔻酸酯13-乙酸酯(PMA)的效力低10倍。在抑制异丙肾上腺素诱导的环磷酸腺苷(cAMP)形成方面,MEZ同样比PMA更有效。使用[3H]佛波醇12,13-二丁酸酯([3H]PDBu)进行的结合竞争研究得出,MEZ和PRA的表观解离常数(Ki)值为50-70 nM。MEZ和PRA的生物学效力与其对主要佛波酯受体的亲和力之间的巨大差异表明,它们在这些细胞中可能通过更复杂的机制发挥作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验